260 related articles for article (PubMed ID: 22138289)
1. Cell-specific effects of miR-221/222 in vessels: molecular mechanism and therapeutic application.
Liu X; Cheng Y; Yang J; Xu L; Zhang C
J Mol Cell Cardiol; 2012 Jan; 52(1):245-55. PubMed ID: 22138289
[TBL] [Abstract][Full Text] [Related]
2. A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia.
Liu X; Cheng Y; Zhang S; Lin Y; Yang J; Zhang C
Circ Res; 2009 Feb; 104(4):476-87. PubMed ID: 19150885
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation.
Cheng Y; Liu X; Yang J; Lin Y; Xu DZ; Lu Q; Deitch EA; Huo Y; Delphin ES; Zhang C
Circ Res; 2009 Jul; 105(2):158-66. PubMed ID: 19542014
[TBL] [Abstract][Full Text] [Related]
4. Flank sequences of miR-145/143 and their aberrant expression in vascular disease: mechanism and therapeutic application.
Liu X; Cheng Y; Yang J; Qin S; Chen X; Tang X; Zhou X; Krall TJ; Zhang C
J Am Heart Assoc; 2013 Oct; 2(6):e000407. PubMed ID: 24166492
[TBL] [Abstract][Full Text] [Related]
5. A receptor-specific function for Notch2 in mediating vascular smooth muscle cell growth arrest through cyclin-dependent kinase inhibitor 1B.
Boucher JM; Harrington A; Rostama B; Lindner V; Liaw L
Circ Res; 2013 Sep; 113(8):975-85. PubMed ID: 23965337
[TBL] [Abstract][Full Text] [Related]
6. miR-424/322 regulates vascular smooth muscle cell phenotype and neointimal formation in the rat.
Merlet E; Atassi F; Motiani RK; Mougenot N; Jacquet A; Nadaud S; Capiod T; Trebak M; Lompré AM; Marchand A
Cardiovasc Res; 2013 Jun; 98(3):458-68. PubMed ID: 23447642
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of cyclin-dependent kinase 2 activity and cyclin A promoter activity in vascular smooth muscle cells by p27(KIP1), an inhibitor of neointima formation in the rat carotid artery.
Chen D; Krasinski K; Sylvester A; Chen J; Nisen PD; Andrés V
J Clin Invest; 1997 May; 99(10):2334-41. PubMed ID: 9153274
[TBL] [Abstract][Full Text] [Related]
8. Engineering the response to vascular injury: divergent effects of deregulated E2F1 expression on vascular smooth muscle cells and endothelial cells result in endothelial recovery and inhibition of neointimal growth.
Goukassian DA; Kishore R; Krasinski K; Dolan C; Luedemann C; Yoon YS; Kearney M; Hanley A; Ma H; Asahara T; Isner JM; Losordo DW
Circ Res; 2003 Jul; 93(2):162-9. PubMed ID: 12829616
[TBL] [Abstract][Full Text] [Related]
9. S-phase kinase-associated protein-2 (Skp2) promotes vascular smooth muscle cell proliferation and neointima formation in vivo.
Wu YJ; Sala-Newby GB; Shu KT; Yeh HI; Nakayama KI; Nakayama K; Newby AC; Bond M
J Vasc Surg; 2009 Nov; 50(5):1135-42. PubMed ID: 19878790
[TBL] [Abstract][Full Text] [Related]
10. Ursodeoxycholic acid inhibits intimal hyperplasia, vascular smooth muscle cell excessive proliferation, migration via blocking miR-21/PTEN/AKT/mTOR signaling pathway.
Huang R; Huang Y; Zeng G; Li M; Jin Y
Cell Cycle; 2020 Apr; 19(8):918-932. PubMed ID: 32202193
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-195 regulates vascular smooth muscle cell phenotype and prevents neointimal formation.
Wang YS; Wang HY; Liao YC; Tsai PC; Chen KC; Cheng HY; Lin RT; Juo SH
Cardiovasc Res; 2012 Sep; 95(4):517-26. PubMed ID: 22802111
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-365 inhibits the proliferation of vascular smooth muscle cells by targeting cyclin D1.
Kim MH; Ham O; Lee SY; Choi E; Lee CY; Park JH; Lee J; Seo HH; Seung M; Choi E; Min PK; Hwang KC
J Cell Biochem; 2014 Oct; 115(10):1752-61. PubMed ID: 24819721
[TBL] [Abstract][Full Text] [Related]
13. Targeting AGGF1 (angiogenic factor with G patch and FHA domains 1) for Blocking Neointimal Formation After Vascular Injury.
Yao Y; Hu Z; Ye J; Hu C; Song Q; Da X; Yu Y; Li H; Xu C; Chen Q; Wang QK
J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28649088
[TBL] [Abstract][Full Text] [Related]
14. Oncological miR-182-3p, a Novel Smooth Muscle Cell Phenotype Modulator, Evidences From Model Rats and Patients.
Sun L; Bai Y; Zhao R; Sun T; Cao R; Wang F; He G; Zhang W; Chen Y; Ye P; Du G
Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1386-97. PubMed ID: 27199451
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation.
Ji R; Cheng Y; Yue J; Yang J; Liu X; Chen H; Dean DB; Zhang C
Circ Res; 2007 Jun; 100(11):1579-88. PubMed ID: 17478730
[TBL] [Abstract][Full Text] [Related]
16. FAM3A promotes vascular smooth muscle cell proliferation and migration and exacerbates neointima formation in rat artery after balloon injury.
Jia S; Chen Z; Li J; Chi Y; Wang J; Li S; Luo Y; Geng B; Wang C; Cui Q; Guan Y; Yang J
J Mol Cell Cardiol; 2014 Sep; 74():173-82. PubMed ID: 24857820
[TBL] [Abstract][Full Text] [Related]
17. The microRNA miR-34c inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia by targeting stem cell factor.
Choe N; Kwon JS; Kim YS; Eom GH; Ahn YK; Baik YH; Park HY; Kook H
Cell Signal; 2015 Jun; 27(6):1056-65. PubMed ID: 25683915
[TBL] [Abstract][Full Text] [Related]
18. Naringenin inhibits angiotensin II-induced vascular smooth muscle cells proliferation and migration and decreases neointimal hyperplasia in balloon injured rat carotid arteries through suppressing oxidative stress.
Xu C; Chen J; Zhang J; Hu X; Zhou X; Lu Z; Jiang H
Biol Pharm Bull; 2013; 36(10):1549-55. PubMed ID: 23912743
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-451 inhibits vascular smooth muscle cell migration and intimal hyperplasia after vascular injury via Ywhaz/p38 MAPK pathway.
Zhang W; Liu D; Han X; Ren J; Zhou P; Ding P
Exp Cell Res; 2019 Jun; 379(2):214-224. PubMed ID: 30930138
[TBL] [Abstract][Full Text] [Related]
20. Endothelial Myocyte Enhancer Factor 2c Inhibits Migration of Smooth Muscle Cells Through Fenestrations in the Internal Elastic Lamina.
Lu YW; Lowery AM; Sun LY; Singer HA; Dai G; Adam AP; Vincent PA; Schwarz JJ
Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1380-1390. PubMed ID: 28473437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
